ASXL1	additional sex comb-like transcriptional regulator 1 gene
BP	blood pressure
CALR	calreticulin gene
CHIP	clonal hematopoiesis of indeterminate potential
CI	confidence interval
DBP	diastolic BP
COVID-19	Coronavirus Disease 2019
CVRF	cardiovascular risk factor
DNA	deoxyribonucleic acid
DNMT3A	DNA methyltransferase 3 alpha gene
ET	essential thrombocythemia
ET-MF	post-essential thrombocythemia myelofibrosis
HTN	hypertension
IDH1/2	isocitrate dehydrogenase 1 or 2 gene
IPSET	International Prognostic Score for Essential Thrombocythemia (score)
JAK2	Janus kinase 2 gene
JAK2V617F	JAK2 gene with valine to phenylalanine substitution on codon 617 mutation
MBP	mean BP
MF	myelofibrosis
MINORS	methodological index for non-randomized observational studies
MMAT	Mixed Methods Appraisal Tool
MOST	Myelofibrosis and Essential Thrombocythemia Observational STudy
MPL	myeloproliferative leukemia protein gene
MPNs	myeloproliferative neoplasms
NOS	nitric oxide synthase
OR	odds ratio
PMF	primary myelofibrosis
PRISMA	Preferred Reporting Items for Systematic reviews and Meta-Analyses
PV	polycythemia vera
PV-MF	post-polycythemia vera myelofibrosis
REVEAL	the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices
SBP	systolic BP
SMF	secondary myelofibrosis
STAT3	signal transducer and activator of transcription 3
T2DM	type 2 diabetes mellitus
TET2	tet methylcytosine dioxygenase 2 gene